Trend to Adopt Digital Pathology Solutions and Opting multiple vendors or Demand for Customized Solutions in Pathology are the Factors Expected to Drive the Digital Pathology Market

The research report "Digital Pathology Market by product (scanners, software solutions/applications, communication systems, storage systems), by application (research & academics, clinical research & toxicology, clinical diagnostics), by usage (human pathology, animal pathology), by end user (hospitals, reference labs & pathologists, pharmaceutical companies, teaching & research institutes, others) and geography – global/region/country forecast to 2026."

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Digital Pathology Market by product, application, usage, end user and geography – global/region/country forecast to 2026"

View detailed report description at https://precisionbusinessinsights.com/market-reports/global-digital-pathology-market/

Digital pathology market started to gain momentum after FDA approved the first whole slide scanner for use in primary diagnosis in April 2017. Many pathology labs in the U.S. and Europe are switching from glass-based reviews using a microscope, to a computer-based workflow for reviewing digital images. Digital Pathology helps pathologists to improve their efficiency in analysis, data storage, and delivering results. The analyzed data can be accessed from anywhere through the internet and can be shared with anyone, rise in dependency on disease diagnostics and the usage of digital pathology in pharmaceuticals, research institutes in the process of drug development which are the main factors for the growth of the market. Introduction of new automated scanners and software applications by the companies driving the growth of the digital pathology market during the forecast period. However due to the high cost of these systems restraints the growth of the market.

Pathology has long been perceived as an area suitable for digitisation and is conferred as the next big opportunity in clinical IT field. The vendors are collaborating with each other to provide inter-compatible digital pathology solutions. Also collaborations and partnerships bring immediate growth effects than acquisition and mergers. Hence co-development and co-marketing are emerging as a prominent trend among vendors of digital pathology solutions. For instance, in December 2018, Inspirata Europe Ltd. – a provider of digital pathology workflow solution, entered into partnership with Hamamatsu Photonics K.K. – a Japan based provider of optical devices, affording shared customers with the ability to view native Hamamatsu .ndpi images within Inspirata’s Dynamyx digital pathology software. In January 2018, Roche and GE Healthcare entered in to co-development and co-marketing partnership for integrated digital diagnostic platform to improve oncology and critical care treatment. Partnership will apply advanced analytics to in-vivo data from GE’s medical imaging and monitoring equipment with in-vitro data from Roche’s biomarker, tissue pathology, genomics and sequencing portfolio

Among all the regions in the global digital pathology market, North America digital pathology is expected to grow at 15.3% of CAGR over the forecast period due to latest approval of digital pathology whole slide scanner for primary diagnosis. Also, due to the introduction of new players in the US market to increase productivity at a larger scale and the usage of digital pathology systems in clinical research. Further due to the COVID-19 pandemic, virtual slides are accessed by the pathologists through the internet which helps them to work from home.

Request a case study or sample research report at https://precisionbusinessinsights.com/request-sample?product_id=16095

Philips collaborated with Ibex Medical Analytics to improve the efficiency, productivity, and accuracy of results in digital pathology. Sectra partnered with Leica Biosystems to get FDA clearance in the digital pathology to overcome competition in the US market. PerkinElmer launched Vectra Polaris, an automated quantitative pathology imaging system. Roche launched two new algorithms uPath HER2 (4B5) and uPath HER2 Dual ISH image analysis in digital pathology for the diagnosis of breast cancer. 3D-Histech uses pannoramic pathology management system to maintain the workflow.

Key market players covered in this report are Perkin Elmer Inc., Olympus Corporation, Spectra AB, Philips Healthcare, Danaher Corporation (Leica Microsystems), ZEISS Group, Roche Diagnostics, DigiPath Corp, 3D-Histech Ltd and GE Healthcare.

Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership. Capacity to provide in-depth research analysis for more than 30 countries. In addition to delivering more than 150 custom solutions, we already have accounts with the top five medical device manufacturers. Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide

This release was published on openPR.